Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Bibliographic Details
Main Authors:	Joseph R. Shaw, Deborah M. Siegal
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	https://doi.org/10.1002/rth2.12367

Similar Items

Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients
by: Kovač Mirjana, et al.
Published: (2022-01-01)

A framework for managing severe DOAC-related bleeding: Recognize, Reverse, Resume, Reduce
by: Stephane Cormier, et al.
Published: (2024-06-01)

Prothrombin Complex Concentrates in Life-Threatening Bleeding
by: Mustafa Burak Sayhan, et al.
Published: (2016-12-01)

Precision medicine in hemostasis: a review of prothrombin complex concentrates and the role of viscoelastic tests in tailoring therapy
by: Iacopo Cappellini, et al.
Published: (2023-10-01)

Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature.
by: Joseph R Shaw, et al.
Published: (2023-01-01)

Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature
by: Joseph R. Shaw, et al.
Published: (2023-01-01)

Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk
by: Rowena Brook, et al.
Published: (2024-07-01)

Risk of Hemorrhoidal Bleeding in Patients Treated with Direct Oral Anticoagulants (DOACs)
by: Carmine Petruzziello, et al.
Published: (2024-07-01)

Hemostasis, Disorders of Coagulation and Transfusion in Cirrhosis
by: Cyriac Abby Philips, et al.
Published: (2015-09-01)

Features of coagulation hemostasis in patients with polytrauma
by: M.B. Vyshynska
Published: (2023-03-01)

Efficacy of Prothrombin Complex Concentrate versus Fresh Frozen Plasma in Patients with Bleeding in the Emergency Department
by: Burak Demirci, et al.
Published: (2022-01-01)

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation
by: Rie Shimizu, et al.
Published: (2024-02-01)

Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale
by: Shaw Shaw, et al.
Published: (2023-07-01)

Features of reaction of coagulation hemostasis in children with pneumonia
by: N. A. Dorokhov, et al.
Published: (2016-02-01)

Hemostasis dan Disseminated Intravascular Coagulation (DIC)
by: Ibnu Umar, et al.
Published: (2020-05-01)

Compression Hemostasis in Refractory Esophageal Bleeding
by: A. Yu. Anisimov, et al.
Published: (2024-01-01)

HEMOSTASIS ABNORMALITIES AND MASSIVE OBSTETRIC BLEEDING
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

USE OF THROMBIN GENERATION ASSAY FOR THE EVALUATION OF COAGULATION AND ANTICOAGULANT ACTIVITY OF HEMOSTASIS SYSTEM IN PATIENTS WITH ABDOMINAL SEPSIS
by: Kh. A. Gamzatov, et al.
Published: (2018-01-01)

Prothrombin Complex Concentrate in Emergency Department
by: Višnja Nesek Adam, et al.
Published: (2022-01-01)

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
by: Dorotea Bozic, et al.
Published: (2023-08-01)

Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score
by: Paolo Prandoni
Published: (2023-10-01)

Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
by: Matthew Laubham, et al.
Published: (2018-05-01)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
by: Julien Favresse, et al.
Published: (2018-04-01)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
by: Michael Hardy, et al.
Published: (2022-03-01)

The Association between Preeclampsia and Defined Polymorphisms in Prothrombin and Coagulation Factor V Genes
by: Zohreh Salari, et al.
Published: (2016-09-01)

Hemostasis and endothelial functionality: the double face of coagulation factors
by: Cristina Olgasi, et al.
Published: (2024-02-01)

DOAC in COVID-19: Yes or No?
by: Roger E. Schutgens
Published: (2021-01-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays
by: Hande Kizilocak, et al.
Published: (2019-06-01)

Hemospray hemostasis in bleeding diffusely ulcerated esophagus
by: Shou-jiang Tang, MD, et al.
Published: (2019-03-01)

Biological evaluation of the effect of sugammadex on hemostasis and bleeding
by: Julien Raft, et al.
Published: (2015-02-01)

Possibilities of Endovascular Hemostasis in Treatment of Pancreatic Bleeding
by: M. S Kapranov, et al.
Published: (2022-02-01)

Prothrombin Complex Concentrates Only After Thromboelastography
by: Ellis Muggleton, et al.
Published: (2019-07-01)

Prothrombin complex concentrates in warfarin anticoagulation reversal
by: Carolina Costa-Lima, et al.
Published: (2012-01-01)

A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding
by: Tessa Jaspers, et al.
Published: (2021-05-01)

Emergency management of major bleeding in a case of maxillofacial trauma and anticoagulation: utility of prothrombin complex concentrates in the shock room
by: Alessandro Morotti, et al.
Published: (2015-03-01)

Validation of the detection method for residual human coagulation factor Ⅺ in human prothrombin complex
by: Yong LIU, et al.
Published: (2023-09-01)

Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry
by: Michihiro Suwa, et al.
Published: (2024-10-01)

Comparing the Effect of DOAC-Stop® and DOAC-Remove® on Apixaban, Rivaroxaban and Dabigatran Prior to Thrombophilia and Lupus Testing
by: Noor-E.-Huddah Malik, et al.
Published: (2024-10-01)

Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis
by: Mercy Halleluyah Periayah, et al.
Published: (2017-10-01)